1-6 of 6
André Bosly
Close
Sort by
Journal Articles

Ofatumumab Monotherapy for Treatment of Patients with Relapsed/Progressive Diffuse Large B-Cell Lymphoma: Results From a Multicenter Phase II Study

Bertrand Coiffier, MD, PhD, André Bosly, MD, Ka Lung Wu, MD, PhD, Gregor Verhoef, MD, PhD, Van Eygen Koen, MD, Giovanni Martinelli, MD, Gabriela Barca, MD, PhD, Andrew Davies, MRCP, PhD, Eve Gallop-Evans, PhD, Swaminathan Padmanabhan, MBBS, MS, Ira V. Gupta, MD, Thomas S. Lin, MD, PhD, Randy L. Davis, DrPH, Nedjad Losic, MSC, Steen Lisby, MD, DMSC, John A. Radford, MD
Journal: Blood
Blood (2010) 116 (21): 3955.
https://doi.org/10.1182/blood.V116.21.3955.3955
Published: 2010
Journal Articles

Interim Analysis of the IELSG-19 Randomised Study of Chlorambucil Alone Versus Chlorambucil Plus Rituximab Versus Rituximab Alone in Extranodal Marginal Zone Lymphomas of Mucosa-Associated Lymphoid Tissue (MALT lymphoma).

Emanuele Zucca, M.D., Annarita Conconi, M.D., Maurizio Martelli, M.D., Catherine Thieblemont, M.D., Peter Johnson, M.D., Armando Lopez Guillermo, M.D., Reda Bouabdallah, M.D., Alessandra Tucci, M.D., Umberto Vitolo, M.D., Bertrand Coiffier, M.D., Ph.D., Liliana Devizzi, M.D., Fabrice Jardin, M.D., Catherine Sebban, M.D., Graziella Pinotti, M.D., Franck Morschhauser, M.D., Ph.D., Ruth Pettengell, M.D., André Bosly, M.D., Ph.D., Emilio Montserrat, M.D., Monica Bellei, Ph.D., Stefano A. Pileri, M.D., Christiane Copie-Bergman, M.D., Elias Campo, M.D., Andrew Jack, M.D., Luca Mazzucchelli, M.D., Irene Floriani, Ph.D., Daniela Garavaglia, B.Sc., Valter Torri, M.D., Franco Cavalli, M.D., Giovanni Martinelli, M.D.
Journal: Blood
Blood (2009) 114 (22): 3939.
https://doi.org/10.1182/blood.V114.22.3939.3939
Published: 2009
Journal Articles

Long Term Results of the GELA Study, R-CHOP vs. CHOP in Elderly Patients with Diffuse Large B-Cell Lymphoma.

Bertrand Coiffier, MD, Pierre Feugier, MD, Catherine Sebban, MD, Reda Bouabdallah, MD, Vincent Delwail, MD, Hervé Tilly, MD, Christian Gisselbrecht, MD, André Bosly, MD, Gilles Salles, MD, Felix Reyes, MD
Journal: Blood
Blood (2004) 104 (11): 1383.
https://doi.org/10.1182/blood.V104.11.1383.1383
Published: 2004
Journal Articles

Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients

Clinical Trials & Observations
Marc André, Nicolas Mounier, Xavier Leleu, Anne Sonet, Pauline Brice, Michel Henry-Amar, Hervé Tilly, Bertrand Coiffier, André Bosly, Pierre Morel, Corinne Haioun, Philippe Gaulard, Felix Reyes, Christian Gisselbrecht, the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
Journal: Blood
Blood (2004) 103 (4): 1222–1228.
https://doi.org/10.1182/blood-2003-04-1124
Published: 2004
Journal Articles

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma

Clinical Trials & Observations
Hervé Tilly, Eric Lepage, Bertrand Coiffier, Michel Blanc, Raoul Herbrecht, André Bosly, Michel Attal, Georges Fillet, Catherine Guettier, Thierry Jo Molina, Christian Gisselbrecht, Félix Reyes, for the Groupe d'Etude des Lymphomes de l'Adulte
Journal: Blood
Blood (2003) 102 (13): 4284–4289.
https://doi.org/10.1182/blood-2003-02-0542
Published: 2003
Journal Articles

Prognostic Significance of T-Cell Phenotype in Aggressive Non-Hodgkin's Lymphomas

Christian Gisselbrecht, Philippe Gaulard, Eric Lepage, Bertrand Coiffier, Josette Brière, Corinne Haioun, Dominique Cazals-Hatem, André Bosly, Luc Xerri, Hervé Tilly, Françoise Berger, Reda Bouhabdallah, Jacques Diebold
Journal: Blood
Blood (1998) 92 (1): 76–82.
https://doi.org/10.1182/blood.V92.1.76.413a19_76_82
Published: 1998